Approval of an epilepsy drug derived from cannabis isn't a slam-dunk win for weed. Here's why
July 19, 2018 at 11:49 AM EDT
The FDA approved an epilepsy drug that is derived from cannabis. Still, it's not a slam-dunk endorsement for the weed industry, this pharmacy professor writes in The Conversation.
